A5020 — Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.

A5020 — Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services. · Informed CitizenryAssembly Bill A5020 aims to change how prescription drugs are priced by requiring greater transparency from Pharmacy Benefit Managers (PBMs). Currently, some PBMs may use a method called "spread pr…Open in Informed Citizenry